mRNA |
1S,3R-RSL-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.056 |
0.09 |
mRNA |
Vinblastine |
GDSC1000 |
pan-cancer |
AAC |
0.058 |
0.09 |
mRNA |
ML210 |
CTRPv2 |
pan-cancer |
AAC |
-0.056 |
0.09 |
mRNA |
TAE684 |
GDSC1000 |
pan-cancer |
AAC |
0.087 |
0.09 |
mRNA |
LY317615 |
GDSC1000 |
pan-cancer |
AAC |
0.057 |
0.09 |
mRNA |
Bexarotene |
GDSC1000 |
pan-cancer |
AAC |
0.06 |
0.09 |
mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.09 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.09 |
mRNA |
Crizotinib |
CCLE |
pan-cancer |
AAC |
0.078 |
0.09 |
mRNA |
R428 |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.09 |